SOE calls for support from ophthalmic community

Article

Prior to the 17th Congress of The European Society of Ophthalmology - Societas Ophthalmologica Europea (SOE) the society is sounding a call to action and warning that its success depends on the support of each and every ophthalmologist.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Related Content
Topcon Healthcare, Inc. appoints Krysten Williams Head of Digital Solutions & Clinical Development – EMEA

Topcon Healthcare, Inc. appoints Krysten Williams Head of Digital Solutions & Clinical Development – EMEA

Sydney M Crago
May 9th 2025
Article

Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
Moorfields, Topcon, IoO announce partnership launch of Cascader

Moorfields, Topcon, IoO announce partnership launch of Cascader

Kassi Filkins
May 7th 2025
Article

Utilizing artificial intelligence (AI), Cascader is a new medical technology company that aims to transform the detection and management of eye disease.

An image of Salt Lake City. Historic downtown area. Concept image for 2025 Association for Research in Vision and Ophthalmology (ARVO). Image credit: ©pabrady63 – stock.adobe.com

Editorial Advisory Board members bring research findings to ARVO

Sydney M Crago
May 5th 2025
Article

Members of the Ophthalmology Times Europe, Ophthalmology Times and Modern Retina editorial advisory boards are present and presenting at the 2025 ARVO meeting

An image of an eye behind glasses. Digital input on the glasses conveys concept of artificial intelligence and computing. Image credit: ©Arsenii – stock.adobe.com

ZEISS debuts Research Data Platform, highlights Boehringer Ingelheim partnership

Martin David Harp
May 2nd 2025
Article

Carl Zeiss Meditec plans to launch the ZEISS RDP in select countries throughout 2025

LuxIA receives CE-MDR certification

LuxIA receives CE-MDR certification

Sydney M Crago
May 1st 2025
Article

LuxIA is designed to screen adult diabetic patients for more-than-mild diabetic retinopathy.

© 2025 MJH Life Sciences

All rights reserved.